These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

725 related articles for article (PubMed ID: 10968781)

  • 1. Therapeutic approaches to bone diseases.
    Rodan GA; Martin TJ
    Science; 2000 Sep; 289(5484):1508-14. PubMed ID: 10968781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical disorders of bone resorption.
    Russell G; Mueller G; Shipman C; Croucher P
    Novartis Found Symp; 2001; 232():251-67; discussion 267-71. PubMed ID: 11277085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is prolonged stimulation of bone growth a therapeutic possibility?
    Mundy GR
    Mol Cell Endocrinol; 1991 Feb; 75(2):C19-25. PubMed ID: 2050268
    [No Abstract]   [Full Text] [Related]  

  • 4. Osteoporosis into the year 2010.
    Mundy GR
    Br J Obstet Gynaecol; 1996 May; 103 Suppl 13():32-7; discussion 37-8. PubMed ID: 8624340
    [No Abstract]   [Full Text] [Related]  

  • 5. Bisphosphonates, specific inhibitors of osteoclast function and a class of drugs for osteoporosis therapy.
    Li B; Ling Chau JF; Wang X; Leong WF
    J Cell Biochem; 2011 May; 112(5):1229-42. PubMed ID: 21465521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small bone-building fragments of parathyroid hormone: new therapeutic agents for osteoporosis.
    Whitfield JF; Morley P
    Trends Pharmacol Sci; 1995 Nov; 16(11):382-6. PubMed ID: 8578607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteoporosis: how should it be treated?
    Odvina CV
    J Investig Med; 2006 Apr; 54(3):114-22. PubMed ID: 16948394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical management of osteoporosis.
    Kirk D; Fish SA
    Am J Manag Care; 2004 Jul; 10(7 Pt 1):445-55. PubMed ID: 15298366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological management of osteogenesis.
    Nardone V; D'Asta F; Brandi ML
    Clinics (Sao Paulo); 2014 Jun; 69(6):438-46. PubMed ID: 24964310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Osteoporosis].
    Matsumoto T
    Ryumachi; 2002 Dec; 42(6):863-71. PubMed ID: 12632605
    [No Abstract]   [Full Text] [Related]  

  • 11. [Regulation of osteoclast activity: a new approach in the therapy of bone diseases].
    Vanhara P; Smarda J
    Cas Lek Cesk; 2006; 145(8):606-10. PubMed ID: 16995415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteoblasts in osteoporosis: past, emerging, and future anabolic targets.
    Marie PJ; Kassem M
    Eur J Endocrinol; 2011 Jul; 165(1):1-10. PubMed ID: 21543379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bisphosphonates: mechanisms of action and clinical use in osteoporosis--an update.
    Fleisch H
    Horm Metab Res; 1997 Mar; 29(3):145-50. PubMed ID: 9137986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Perspectives on therapy with diphosphonates in non-malignant diseases].
    Willvonseder R; Resch H
    Z Gerontol; 1990; 23(1):39-42. PubMed ID: 2183510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psoralidin, a prenylated coumestan, as a novel anti-osteoporosis candidate to enhance bone formation of osteoblasts and decrease bone resorption of osteoclasts.
    Zhai Y; Li Y; Wang Y; Cui J; Feng K; Kong X; Chen L
    Eur J Pharmacol; 2017 Apr; 801():62-71. PubMed ID: 28283388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological diversity among drugs that inhibit bone resorption.
    Russell RG
    Curr Opin Pharmacol; 2015 Jun; 22():115-30. PubMed ID: 26048735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mandibular bone formation rates in aged ovariectomized rats treated with anti-resorptive agents alone and in combination with intermittent parathyroid hormone.
    Hunziker J; Wronski TJ; Miller SC
    J Dent Res; 2000 Jun; 79(6):1431-8. PubMed ID: 10890724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of osteoclast mediated bone resorption--rationale for the design of new therapeutics.
    Väänänen K
    Adv Drug Deliv Rev; 2005 May; 57(7):959-71. PubMed ID: 15876398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Current research in therapy of postmenopausal osteoporosis (author's transl)].
    Laroche C; Detilleux M; Sereni D
    Sem Hop; 1979 Feb 18-25; 55(7-8):325-9. PubMed ID: 220722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The treatment of osteoporosis. Antiresorptive therapy.
    Miller PD
    Clin Lab Med; 2000 Sep; 20(3):603-22, viii. PubMed ID: 10986624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.